Abraham Jacob, Mudd James O, Kapur Navin K, Klein Kelly, Champion Hunter C, Wittstein Ilan S
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Am Coll Cardiol. 2009 Apr 14;53(15):1320-5. doi: 10.1016/j.jacc.2009.02.020.
The aim of this study was to report a series of patients with stress cardiomyopathy precipitated by the intravenous administration of catecholamines and beta-receptor agonists.
Stress cardiomyopathy is a syndrome of transient cardiac dysfunction precipitated by intense emotional or physical stress. Excessive sympathetic stimulation is believed to be central to the pathogenesis of this disorder, but a causal link has not been convincingly demonstrated.
We observed 9 cases of stress cardiomyopathy precipitated immediately by the intravenous administration of epinephrine (n = 6) or dobutamine (n = 3). Patients were evaluated with coronary angiography and with serial echocardiography, electrocardiography, and cardiac enzymes.
The median age was 44 years (interquartile range [IQR]: 30 to 48 years), and 7 (78%) were woman. Troponin-I was mildly elevated (median 4.07 ng/ml, IQR: 0.47 to 5.63 ng/ml), but none of the patients undergoing angiography had obstructive coronary disease. All patients developed corrected QT interval (QTc interval) prolongation (median QTc interval 504 ms, IQR: 477 to 568 ms) within 24 h of receiving drug. All 3 previously described variants of left ventricular "ballooning" (apical, midventricular, and basal) were observed. The median ejection fraction on admission was 35% (IQR: 35% to 40%). During follow-up (median 7 days, IQR: 4 to 13 days) there was recovery of left ventricular systolic function in all patients (median ejection fraction 55%, IQR: 40% to 60%, p < 0.001 vs. admission).
Exposure to catecholamines and beta-receptor agonists used routinely during procedures and diagnostic tests can precipitate all the features of stress cardiomyopathy, including cardiac isoenzyme elevation, QTc interval prolongation, and rapidly reversible cardiac dysfunction. These observations strongly implicate excessive sympathetic stimulation as central to the pathogenesis of this unique syndrome.
本研究旨在报告一系列因静脉注射儿茶酚胺和β受体激动剂而诱发应激性心肌病的患者。
应激性心肌病是一种由强烈情绪或身体应激诱发的短暂性心脏功能障碍综合征。过度的交感神经刺激被认为是该疾病发病机制的核心,但因果关系尚未得到令人信服的证实。
我们观察了9例因静脉注射肾上腺素(n = 6)或多巴酚丁胺(n = 3)而立即诱发应激性心肌病的患者。对患者进行了冠状动脉造影以及系列超声心动图、心电图和心肌酶检查。
患者的中位年龄为44岁(四分位间距[IQR]:30至48岁),7名(78%)为女性。肌钙蛋白I轻度升高(中位值4.07 ng/ml,IQR:0.47至5.63 ng/ml),但接受血管造影的患者均无阻塞性冠状动脉疾病。所有患者在接受药物治疗后24小时内均出现校正QT间期(QTc间期)延长(中位QTc间期504 ms,IQR:477至568 ms)。观察到了先前描述的左心室“气球样变”的所有3种类型(心尖部、心室中部和基底部)。入院时的中位射血分数为35%(IQR:35%至40%)。在随访期间(中位7天,IQR:4至13天),所有患者的左心室收缩功能均恢复(中位射血分数55%,IQR:40%至60%,与入院时相比p < 0.001)。
在手术和诊断检查过程中常规使用的儿茶酚胺和β受体激动剂可诱发应激性心肌病的所有特征,包括心脏同工酶升高、QTc间期延长和快速可逆的心脏功能障碍。这些观察结果强烈表明过度交感神经刺激是这种独特综合征发病机制中的核心因素。